ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members. Disclaimer ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives. Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services. |
|
|||||||||||
Fears Over Naltrexone Unfounded, Finds ReviewThursday 17 January 2019
From The University of Manchester:
Fears over life-saving drug unfounded, finds review Fears over a drug that can be used to treat alcohol addiction are unfounded, according to its first ever systematic review, led by academics at The University of Manchester. Though the study found no evidence of any serious side effects linked to Naltrexone, many doctors hold back from prescribing the drug, often citing liver toxicity as a reason. The review of 89 placebo controlled randomized clinical trials of naltrexone is based on 11,194 participants published in BMC Medicine. ... Naltrexone is being investigated for a range of other conditions such as other addictions, gambling and other impulse control disorders. Anecdotal evidence also suggests that at a very low dose, it may also be able to treat a range of immune-modulated conditions including Crohn’s disease, HIV, multiple sclerosis, fibromyalgia and Chronic Fatigue Syndrome (ME/CFS).
blog comments powered by Disqus |
||||||||||||
|
Registered Charity 3104
Email:
sacfs@sacfs.asn.au
Mailing address:
PO Box 322,
Modbury North,
South Australia 5092
Phone:
1300 128 339
Office Hours:
Monday - Friday,
10am - 4pm
(phone)